Enrique Barbieri Co-Director, Texas Manufacturing Assistance Center – Gulf Coast (TMAC) University of Houston Enrique Barbieri received his Ph.D. from the Electrical Engineering Department at The Ohio State University. He was Associate Professor and Chair of the Electrical Engineering & Computer Science Department at Tulane University (96-98). He is currently ...
Co-Director, Texas Manufacturing Assistance Center – Gulf Coast (TMAC)
University of Houston
Enrique Barbieri received his Ph.D. from the Electrical Engineering Department at The Ohio State University. He was Associate Professor and Chair of the Electrical Engineering & Computer Science Department at Tulane University (96-98). He is currently a Professor at the University of Houston, Chairs the Department of Engineering Technology, and co-directs the Texas Manufacturing Assistance Center (TMAC) – Gulf Coast. His teaching interests are in Microprocessors, Signals, Systems, and Control. He has been the PI/Co-PI of projects from NASA, NSF, the Louisiana Board of Regents, the Gulf South Research Foundation, the University of Houston, the Professional Surveyors Educational Foundation, AT&T, and others.
Peter M. Clarke
Vice President, Production and Technical Processes, Introgen Therapeutics, Inc.
Dr. Clarke joined Introgen in 2004 after 23 years in the biotechnology field working in both Research and Manufacturing. Dr. Clarke has held positions of increasing importance in both start-up and established European and U.S. based biopharmaceutical companies such as Medeva Pharma and Chiron Vaccines. Most recently he worked for Bayer Biological Products as Director of Manufacturing with a focus on North American licensure and launch of a novel immunoglobulin. In 1984 Dr. Clarke worked on a project team that won the British Royal Academy’s Pollution Abatement Technology Award for the design of a cyanide spill treatment system using an enzyme produced from a Fusarium species. In addition to his many awards and achievements, Dr. Clarke has supported three new product licenses (in North America and Europe) including a novel Immunoglobulin product, a recombinant acellular pertussis combination vaccine and a recombinant Hepatitis B vaccine. His degrees include: BSC in Biochemistry from Sheffield University, England; Ph.D. in Microbial Physiology and DIC in Biochemistry, Imperial College of Science and Technology, London, England.
Director, Life Sciences Program, Houston Technology Center
Deborah Mansfield is the business development director of the Life Sciences Program, Houston Technology Center - a non-profit business accelerator assisting the commercialization of emerging technology companies. Deborah has an extensive background in management, non-equity funding, entrepreneurship, compliance, and research in the Life Sciences sector. She has provided operations support to the Governors Council on Science and Biotechnology Development and currently acts as the Administrative Liaison for Life Science Technologies for the Gulf Coast Regional Center of Innovation and Commercialization, Texas Emerging Technology Fund. She is an avid participant in many Houston networking groups including the Nanotechnology Foundation of Texas and Steering committee for the Bio/Medical Technology Club of Houston. Mrs. Mansfield has an MBA from Our Lady of the Lake University, MS from Pennsylvania State University, and BS from California State University of Pennsylvania.
M. Gary Miertschin
Automated Solutions Sales Consultant, Beckman Coulter, Inc.
M. Gary Miertschin, Automated Solutions Consultant, has over 10 years of experience in industrial and laboratory automation and robotics. He has been employed with Beckman Coulter, Inc. for over 5 years and is responsible the Automate Solutions business sector in the southeastern United States. His role within Beckman Coulter, is to manage the sale and implementation of liquid handling robotic systems and integrated automation. In this capacity he has worked in a number of high throughput environments including drug screening, microarray production/ processing, genotyping and sequencing. Prior to Beckman Coulter, he spent 6 years involved in industrial automation and robotics. He has a Bachelors of Science from the University of Houston.
J. Donald Payne
President and CEO, Nanospectra Biosciences, Inc.
Mr. Payne is the President and CEO of Nanospectra Biosciences, a Rice University spin-out developing medical therapeutic and diagnostic applications. As CEO, he has led NBI through preclinical development of its broad-based cancer therapy and plans to move this technology into clinical trials by the end of 2006. Mr. Payne has held progressively senior positions in the life science industry since 1992, holding executive positions with biopharmaceutical, tissue engineering and diagnostic companies. Prior to 1992, he held executive positions in the energy industry. He has an MBA from Rice University and a BBA from Texas A&M University.
Jack W. Smith
Dean, School of Health Information Sciences, University of Texas Health Science Center – Houston.
Jack W. Smith, MD, PhD was recruited from Ohio State University to become the first Chairman of the Department of Health Informatics at UT Health Science Center – Houston. In December 2005 he became Dean for the School of Health Information Sciences at the University. In addition, he is Team Leader of Medical Informatics and Healthcare Systems at the NASA - Johnson Space Center. His research interests are artificial intelligence, modeling problem-solving in healthcare, implementation of decision support and tutoring systems, modeling complex human problem-solving and the application of cognitive science to understanding human-computer interaction. Dr. Smith is a physician board certified in Pathology and has a doctorate in Computer Science in the area of Artificial Intelligence.